Cargando…
Risk factors for adverse events occurring after recovery from stereotactic brain biopsy in dogs with primary intracranial neoplasia
BACKGROUND: Stereotactic brain biopsy (SBB) allows for histopathologic diagnosis of brain tumors. Adverse events (AE) occur in 5 to 29% of dogs after SBB, but risk factors associated with developing AE are poorly described. OBJECTIVE: Identify clinicopathologic, diagnostic imaging, or procedural var...
Autores principales: | Shinn, Richard L., Kani, Yukitaka, Hsu, Fang‐Chi, Rossmeisl, John H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7517515/ https://www.ncbi.nlm.nih.gov/pubmed/32924201 http://dx.doi.org/10.1111/jvim.15885 |
Ejemplares similares
-
Diagnostic accuracy of stereotactic brain biopsy for intracranial neoplasia in dogs: Comparison of biopsy, surgical resection, and necropsy specimens
por: Kani, Yukitaka, et al.
Publicado: (2019) -
Comparison of direct measurement of intracranial pressures and presumptive clinical and magnetic resonance imaging indicators of intracranial hypertension in dogs with brain tumors
por: Giannasi, Savannah, et al.
Publicado: (2020) -
Comparison of linear and volumetric criteria for the determination of therapeutic response in dogs with intracranial gliomas
por: Garcia Mora, Josefa Karina, et al.
Publicado: (2022) -
Incidence, risk factors, and outcomes for early postoperative seizures in dogs with rostrotentorial brain tumors after intracranial surgery
por: Parker, Rell L., et al.
Publicado: (2022) -
CyberKnife stereotactic radiotherapy for treatment of primary intracranial tumors in dogs
por: Carter, Gabrielle L., et al.
Publicado: (2021)